Cellular reprogramming to reset epigenetic signatures

Kyle J Hewitt, Jonathan A. Garlick

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

The controlled differentiation of induced pluripotent stem cells (iPSC) towards clinically-relevant cell types has benefitted from epigenetic profiling of lineage-specific markers to confirm the phenotype of iPSC-derived cells. Mapping epigenetic marks throughout the genome has identified unique changes which occur in the DNA methylation profile of cells as they differentiate to specific cell types. Beyond characterizing the development of cells derived from pluripotent stem cells, the process of reprogramming cells to iPSC resets lineage-specific DNA methylation marks established during differentiation to specific somatic cell types. This property of reprogramming has potential utility in reverting aberrant epigenetic alterations in nuclear organization that are linked to disease progression. Since DNA methylation marks are reset following reprogramming, and contribute to restarting developmental programs, it is possible that DNA methylation marks associated with the disease state may also be erased in these cells. The subsequent differentiation of such cells could result in cell progeny that will function effectively as therapeutically-competent cell types for use in regenerative medicine. This suggests that through reprogramming it may be possible to directly modify the epigenetic memory of diseased cells and help to normalize their cellular phenotype, while also broadening our understanding of disease pathogenesis.

Original languageEnglish (US)
Pages (from-to)841-848
Number of pages8
JournalMolecular Aspects of Medicine
Volume34
Issue number4
DOIs
StatePublished - Jul 1 2013

Fingerprint

Stem cells
Epigenomics
DNA Methylation
Induced Pluripotent Stem Cells
Genes
Cells
Data storage equipment
Cellular Reprogramming
Phenotype
Pluripotent Stem Cells
Regenerative Medicine
Cell Lineage
Disease Progression
Cell Differentiation
Genome

Keywords

  • DNA methylation
  • Epigenetics
  • Induced pluripotent stem cells
  • Profiling
  • Reprogramming

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Cellular reprogramming to reset epigenetic signatures. / Hewitt, Kyle J; Garlick, Jonathan A.

In: Molecular Aspects of Medicine, Vol. 34, No. 4, 01.07.2013, p. 841-848.

Research output: Contribution to journalReview article

Hewitt, Kyle J ; Garlick, Jonathan A. / Cellular reprogramming to reset epigenetic signatures. In: Molecular Aspects of Medicine. 2013 ; Vol. 34, No. 4. pp. 841-848.
@article{84e97528d2c74547bdb915bc0da35eac,
title = "Cellular reprogramming to reset epigenetic signatures",
abstract = "The controlled differentiation of induced pluripotent stem cells (iPSC) towards clinically-relevant cell types has benefitted from epigenetic profiling of lineage-specific markers to confirm the phenotype of iPSC-derived cells. Mapping epigenetic marks throughout the genome has identified unique changes which occur in the DNA methylation profile of cells as they differentiate to specific cell types. Beyond characterizing the development of cells derived from pluripotent stem cells, the process of reprogramming cells to iPSC resets lineage-specific DNA methylation marks established during differentiation to specific somatic cell types. This property of reprogramming has potential utility in reverting aberrant epigenetic alterations in nuclear organization that are linked to disease progression. Since DNA methylation marks are reset following reprogramming, and contribute to restarting developmental programs, it is possible that DNA methylation marks associated with the disease state may also be erased in these cells. The subsequent differentiation of such cells could result in cell progeny that will function effectively as therapeutically-competent cell types for use in regenerative medicine. This suggests that through reprogramming it may be possible to directly modify the epigenetic memory of diseased cells and help to normalize their cellular phenotype, while also broadening our understanding of disease pathogenesis.",
keywords = "DNA methylation, Epigenetics, Induced pluripotent stem cells, Profiling, Reprogramming",
author = "Hewitt, {Kyle J} and Garlick, {Jonathan A.}",
year = "2013",
month = "7",
day = "1",
doi = "10.1016/j.mam.2012.08.002",
language = "English (US)",
volume = "34",
pages = "841--848",
journal = "Molecular Aspects of Medicine",
issn = "0098-2997",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Cellular reprogramming to reset epigenetic signatures

AU - Hewitt, Kyle J

AU - Garlick, Jonathan A.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - The controlled differentiation of induced pluripotent stem cells (iPSC) towards clinically-relevant cell types has benefitted from epigenetic profiling of lineage-specific markers to confirm the phenotype of iPSC-derived cells. Mapping epigenetic marks throughout the genome has identified unique changes which occur in the DNA methylation profile of cells as they differentiate to specific cell types. Beyond characterizing the development of cells derived from pluripotent stem cells, the process of reprogramming cells to iPSC resets lineage-specific DNA methylation marks established during differentiation to specific somatic cell types. This property of reprogramming has potential utility in reverting aberrant epigenetic alterations in nuclear organization that are linked to disease progression. Since DNA methylation marks are reset following reprogramming, and contribute to restarting developmental programs, it is possible that DNA methylation marks associated with the disease state may also be erased in these cells. The subsequent differentiation of such cells could result in cell progeny that will function effectively as therapeutically-competent cell types for use in regenerative medicine. This suggests that through reprogramming it may be possible to directly modify the epigenetic memory of diseased cells and help to normalize their cellular phenotype, while also broadening our understanding of disease pathogenesis.

AB - The controlled differentiation of induced pluripotent stem cells (iPSC) towards clinically-relevant cell types has benefitted from epigenetic profiling of lineage-specific markers to confirm the phenotype of iPSC-derived cells. Mapping epigenetic marks throughout the genome has identified unique changes which occur in the DNA methylation profile of cells as they differentiate to specific cell types. Beyond characterizing the development of cells derived from pluripotent stem cells, the process of reprogramming cells to iPSC resets lineage-specific DNA methylation marks established during differentiation to specific somatic cell types. This property of reprogramming has potential utility in reverting aberrant epigenetic alterations in nuclear organization that are linked to disease progression. Since DNA methylation marks are reset following reprogramming, and contribute to restarting developmental programs, it is possible that DNA methylation marks associated with the disease state may also be erased in these cells. The subsequent differentiation of such cells could result in cell progeny that will function effectively as therapeutically-competent cell types for use in regenerative medicine. This suggests that through reprogramming it may be possible to directly modify the epigenetic memory of diseased cells and help to normalize their cellular phenotype, while also broadening our understanding of disease pathogenesis.

KW - DNA methylation

KW - Epigenetics

KW - Induced pluripotent stem cells

KW - Profiling

KW - Reprogramming

UR - http://www.scopus.com/inward/record.url?scp=84878109700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878109700&partnerID=8YFLogxK

U2 - 10.1016/j.mam.2012.08.002

DO - 10.1016/j.mam.2012.08.002

M3 - Review article

VL - 34

SP - 841

EP - 848

JO - Molecular Aspects of Medicine

JF - Molecular Aspects of Medicine

SN - 0098-2997

IS - 4

ER -